Literature DB >> 20879013

Gender disparity in liver transplant waiting-list mortality: the importance of kidney function.

Ayse L Mindikoglu1, Arie Regev, Stephen L Seliger, Laurence S Magder.   

Abstract

Previous studies of men and women on the liver transplantation (LT) waiting list, without taking transplantation rates into account, have suggested a higher risk of mortality for women on the waiting list. The objective of this study was to compare men and women with respect to dying within 3 years of registration on the LT waiting list and to take into account both the immediate mortality risks and the transplantation rates. The analysis was based on Organ Procurement and Transplantation Network data for patients with end-stage liver disease (ESLD) on the waiting list who were registered between February 2002 and August 2009. Competing risk survival analysis was performed to assess the gender disparity in waiting-list mortality; 42,322 patients and 610,762 person-months of waiting-list experience were included in the analysis. The risk of dying within 3 years of listing was 19% and 17% in women and men, respectively (P < 0.0001). Among patients with kidney disease and especially those not on dialysis with an estimated glomerular filtration rate (eGFR) ≥15 and <30 mL/minute/1.73 m(2), women had a substantially higher risk of dying on the waiting list within 3 years of registration versus men (26% versus 20%, P = 0.001). This disparity was related to lower transplantation rates in women (transplantation rate ratio = 0.68, P < 0.0001). Controlling for eGFR and other variables related to mortality risk, we found that the overall female-male disparity disappeared. In conclusion, among patients with ESLD and kidney dysfunction who are not on dialysis, there is a substantial gender disparity in LT waiting-list mortality. Our analysis suggests as an explanation the fact that women have lower transplantation rates than men in this group. The lower transplantation rates can be explained in part by the fact that Model for End-Stage Liver Disease scores tend to be lower for women versus men because they are based on serum creatinine rather than the glomerular filtration rate.
© 2010 AASLD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20879013      PMCID: PMC3119710          DOI: 10.1002/lt.22121

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  27 in total

1.  Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis.

Authors:  R P Woitas; B Stoffel-Wagner; S Flommersfeld; U Poege; P Schiedermaier; H U Klehr; U Spengler; F Bidlingmaier; T Sauerbruch
Journal:  Clin Chem       Date:  2000-05       Impact factor: 8.327

2.  Late initiation of dialysis among women and ethnic minorities in the United States.

Authors:  Annamaria T Kausz; Gregorio T Obrador; Pradeep Arora; Robin Ruthazer; Andrew S Levey; Brian J G Pereira
Journal:  J Am Soc Nephrol       Date:  2000-12       Impact factor: 10.121

3.  Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population.

Authors:  G T Obrador; P Arora; A T Kausz; R Ruthazer; B J Pereira; A S Levey
Journal:  Kidney Int       Date:  1999-12       Impact factor: 10.612

4.  Race and sex disparities in liver transplantation: progress toward achieving equal access?

Authors:  David A Axelrod; Elizabeth A Pomfret
Journal:  JAMA       Date:  2008-11-26       Impact factor: 56.272

5.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

Authors:  M Malinchoc; P S Kamath; F D Gordon; C J Peine; J Rank; P C ter Borg
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

6.  Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome.

Authors:  S Demirtaş; A Bozbaş; A Akbay; Y Yavuz; L Karaca
Journal:  Clin Chim Acta       Date:  2001-09-25       Impact factor: 3.786

7.  Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver.

Authors:  A L Gerbes; V Gülberg; M Bilzer; M Vogeser
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

Review 8.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

9.  Prediction of GFR in liver transplant candidates.

Authors:  Paul A Skluzacek; Robert G Szewc; Charles R Nolan; Daniel J Riley; Shuko Lee; Pablo E Pergola
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

10.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

View more
  35 in total

1.  Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation.

Authors:  Alina M Allen; Julie K Heimbach; Joseph J Larson; Kristin C Mara; W Ray Kim; Patrick S Kamath; Terry M Therneau
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

Review 2.  Gender-based disparities in access to and outcomes of liver transplantation.

Authors:  Omobonike O Oloruntoba; Cynthia A Moylan
Journal:  World J Hepatol       Date:  2015-03-27

3.  Liver-related mortality is similar among men and women with cirrhosis.

Authors:  Nikhilesh R Mazumder; Stela Celaj; Kofi Atiemo; Amna Daud; Kathryn L Jackson; Abel Kho; Josh Levitsky; Daniela P Ladner
Journal:  J Hepatol       Date:  2020-04-25       Impact factor: 25.083

4.  Shorter Height Is Associated With Lower Probability of Liver Transplantation in Patients With Hepatocellular Carcinoma.

Authors:  Eric Lee; Monika Sarkar; Jennifer Dodge; Maureen Kohi; Neil Mehta
Journal:  Transplantation       Date:  2020-05       Impact factor: 4.939

5.  Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis.

Authors:  A L Mindikoglu; J P Raufman; S L Seliger; C D Howell; L S Magder
Journal:  Transplant Proc       Date:  2011-09       Impact factor: 1.066

6.  Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list.

Authors:  Laurence S Magder; Arie Regev; Ayse L Mindikoglu
Journal:  Transpl Int       Date:  2012-02-02       Impact factor: 3.782

7.  Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List.

Authors:  Nathalie H Urrunaga; Laurence S Magder; Matthew R Weir; Don C Rockey; Ayse L Mindikoglu
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

8.  Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.

Authors:  Ayse L Mindikoglu; Antone R Opekun; William E Mitch; Laurence S Magder; Robert H Christenson; Thomas C Dowling; Matthew R Weir; Stephen L Seliger; Charles D Howell; Jean-Pierre Raufman; Abbas Rana; John A Goss; Saira A Khaderi; John M Vierling
Journal:  Dig Dis Sci       Date:  2018-02-01       Impact factor: 3.199

9.  Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.

Authors:  Pratima Sharma; Douglas E Schaubel; Emily E Messersmith; Mary K Guidinger; Robert M Merion
Journal:  Liver Transpl       Date:  2012-12       Impact factor: 5.799

10.  Impact of estimated liver volume and liver weight on gender disparity in liver transplantation.

Authors:  Ayse L Mindikoglu; Sukru H Emre; Laurence S Magder
Journal:  Liver Transpl       Date:  2012-12-12       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.